The anaesthetic management of a 38-year-old woman having excision of a meningioma involving the superior sagittal sinus is described. The procedure was performed using low flow moderate hypothermic cardiopulmonary bypass with central cannulation. Relevant literature is reviewed.
Complex neurosurgical cases have significant morbidity and mortality. Over the past two decades, a renewed interest in the use of hypothermic cardiopulmonary bypass has occurred. Improved bypass techniques and a better understanding of pathophysiology may have reduced surgical and anaesthetic risk. A recent retrospective review suggested that only giant and complex posterior circulation aneurysms that cannot be treated by conventional surgery or endovascular coiling are indications for hypothermic circulatory arrest 1 .
We present a case using cardiopulmonary bypass for an additional indication, and review the current literature on anaesthetic considerations for the associated surgery. Rather than being initiated to control arterial pressure and aid in aneurysmal clipping, hypothermic cardiopulmonary bypass was considered necessary to minimize flow through a venous structure, enabling safe and successful exposure of a neurovascular tumour whilst being able to rapidly manipulate cerebral venous pressure and cerebral blood flow.
CASE HISTORY
A 38-year-old woman, previously well, presented with a history of occipital headache and neck pain. On clinical examination she had mild papilloedema with no other significant neurological signs. An MRI scan subsequently showed a tumour, most likely a meningioma, attached to and encroaching into the superior sagittal sinus with involvement of over 50% of its length.
Other routine tests were all normal and a preoperative echocardiogram showed normal left ventricular function with no aortic regurgitation.
Discussion between the neurosurgeon, cardiac surgeon and anaesthetic team led to the choice of a technique using cardiopulmonary bypass with low flows and, if necessary, circulatory standstill, in order to control intraoperative cerebral venous pressures and cerebral blood flow.
The patient was premedicated with intramuscular midazolam 5 mg. Prior to induction, a subclavian pulmonary artery catheter, radial arterial line, multilumen antecubital longline and peripheral intravenous cannulae were placed. Anaesthetic induction consisted of propofol 2 mg/kg, fentanyl 2 µg/kg and vecuronium 0.1 mg/kg. The patient was positioned supine and anaesthesia was maintained with oxygen/ nitrous oxide, FiO 2 0.4, propofol infusion 8 mg/kg/h CASE REPORT which after 15 minutes was reduced to 4 to 5 mg/kg/h. Intraoperatively, arterial, central venous pressure (CVP) and pulmonary artery pressure were continuously monitored and both nasopharyngeal and pulmonary artery temperatures were monitored. Limited surgical access meant cortical temperature could not be measured directly. A trained technician using a standard electroencephalograph (EEG) monitor (Medelec DG examiner, paper speed 30 mm/sec, sensitivity 10 uV/mm and a filtered frequency of 0.5 to 70 Hz), continuously monitored a raw unprocessed EEG. Standard 10 to 20 international EEG lead placement was used, surgical access allowing only 16 channel monitoring with subsequent reduction during the case to 12 channels due to loss of electrode contact.
The patient was given dexamethasone 16 mg, phenytoin 1g and cefotaxime 1g. Mean arterial pressure was maintained at 70 to 80 mmHg and temperature allowed to passively decrease to 34.5°C, arterial carbon dioxide being maintained at 30 mmHg. An additional 500 µg fentanyl was given prior to sternotomy and nitrous oxide discontinued.
Initially a superior hemi-sternotomy was performed and aortic and right atrial purse strings were placed. Next a midline sagittal craniotomy flap was raised from coronal suture to inion. At this point the patient was heparinized with 300 U/kg and placed on cardiopulmonary bypass using a single aortic and a selective caval cannulation. Cardiopulmonary bypass involved the use of a standard cardiopulmonary bypass machine (COBE Medtronic), with roller pumps, membrane oxygenator, reservoir but no arterial filter. On initiation of cardiopulmonary bypass, aprotinin 500,000 IU was given plus an additional 500,000 IU over the next two hours.
During cardiopulmonary bypass the temperature was reduced to 23 to 24°C over 15 minutes and maintained at this level, and non-pulsatile perfusion was used with a mean arterial pressure of 45 to 50 mmHg. During this period and until rewarmed, the heart remained spontaneously in asystole. Once the temperature reached 24°C, flow rates of 70 ml/kg/min were reduced to 30 ml/kg/min. CVP was maintained at 2 to 6 mmHg and mixed venous oxygen saturation remained greater than 85% for the duration of bypass.
After cooling to 23.5°C, the EEG still exhibited some spontaneous electrical activity. The propofol infusion was discontinued and a thiopentone infusion commenced at 1g/h, then reduced to 500 mg/h after 10 minutes resulting in an isoelectric EEG. It was continued at this dose for 90 minutes and then reduced further to 250 mg/h for the duration of bypass.
The activated clotting time (ACT) as measured with Kaolin activator was maintained at >500 seconds. The haematocrit during bypass was 0.22 to 0.27. Blood glucose remained between 7 and 12 mmol/l. Alpha stat acid-base management was used with carbon dioxide tension kept between 27 and 30 mmHg.
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Once the patient was stabilized on cardiopulmonary bypass, the dura was opened, the sagittal sinus was ligated proximally and opened, and excision of the tumour commenced.
Midway through excision of the tumour it was noted that there was no back bleeding from the distal end of the sinus. Because of concerns of air entrainment into the sinus and right atrium, 15 cm H 2 O PEEP was applied and CVP increased to 6 mmHg, which resulted in back bleeding. Thereafter the distal end of the sinus was surgically clamped for the duration of excision. Once the tumour was completely excised, a dural patch was placed to the anterior defect of the sagittal sinus. The sinus was then de-aired and sutured, and ligatures from both ends were removed. Circulatory arrest was not required to control venous bleeding during the case.
The patient was gradually rewarmed from 24 to 38°C over 30 minutes, warm air convection heating was commenced and arterial pressure increased to 70 to 75 mmHg and after 600 ml ultrafiltrate was removed, the patient was weaned from cardiopulmonary bypass. During this period the patient required inotropic support with increasing doses of dopamine from 5 to 12.5 µg/kg/min and noradrenaline titrated to achieve a mean arterial pressure of 70 to 80 mmHg. Total cardiopulmonary bypass time was 147 minutes. The EEG continued to have two minute symmetrical burst suppression on rewarming.
Once off bypass the core temperature decreased to 34°C despite active external convection warming. Protamine 400 mg was given slowly and the haematocrit raised to 0.30. Standard coagulation studies revealed an APTT 60 seconds, INR 2.0 and platelet count of 57 x 10 9 /l, which were immediately corrected by the administration of 6 units fresh frozen plasma, and 8 units of platelets. After adequate haemostasis was achieved and a subdural intracranial pressure monitor was inserted, the craniotomy was closed. The sternum was then closed with three sternal wires.
The patient was transferred to an intensive care unit where she remained ventilated to achieve normocarbia, paralyzed and sedated with propofol and morphine infusions. Her inotropes were weaned over 36 hours and she was extubated two days postoperatively. On waking she had a mild right-sided hemiparesis and some difficulty swallowing which resolved over three days. A postoperative MRI scan was unremarkable and she was commenced on aspirin and discharged home six days postoperatively.
On the 11th postoperative day the patient was readmitted with a 48 hour history of headache, nausea and vomiting which resolved with dexamethasone and on day 16 was discharged home. An angiogram performed subsequently, as an outpatient, showed an intact sagittal sinus with good venous flow.
DISCUSSION
Hypothermic cardiopulmonary bypass for neurosurgical procedures is not a new technique. Initial interest in this procedure began in the early 1960s but faded when mortalities of up to 25% and significant morbidities of approximately 20% were reported. Approximately half of these mortalities were due to complications of bypass, systemic hypothermia and coagulopathy 2, 3 .
Today the mortality has decreased to levels that make this complicated procedure an acceptable alternative for complicated neurovascular pathology. Better surgical techniques and equipment, better cardiopulmonary bypass techniques, a clearer understanding of hypothermia and coagulopathy after bypass, and improved monitoring, have all contributed to this improved outcome. In a retrospective review of the literature on hypothermic cardiac standstill for cerebral aneurysm surgery since 1980, Connolly 4 reviewed over 100 patients and estimated a mortality of 10% with good results in 82%, but pointed out that these were either single case reports or small clinical series.
The two large clinical series published since 1990 describe 51 patients over 10 years 4 and 62 patients over 12 years 1 , with similar morbidity and mortality figures. In both these reviews the authors describe only their anaesthetic and cardiopulmonary bypass techniques, and to date, there remains no controlled study looking specifically at adult neurosurgical patients.
Lawton, because of the relatively high morbidity and mortality compared with conventional surgery or interventional radiology, indicated that only giant and posterior circulation aneurysms which cannot be treated by conventional surgery or endovascular coiling are indications for cardiopulmonary bypass 1 . This case offers a new indication for cardiopulmonary bypass (CPB) for a neurosurgical procedure. In order to provide prolonged exposure to an open sagittal sinus it was decided that cardiopulmonary bypass with a reduction in cerebral blood flow was the safest option. Under conventional surgical conditions, if the sinus was clamped it was thought that there would be venous congestion and a significant risk of cerebral oedema. Additionally, the extent of the tumour and presence of draining tributaries meant that clamping would be unlikely to guarantee an avascular field. Alternatively if the sagittal sinus were not clamped N. BURGESS, P. ISERT there would be either uncontrolled bleeding or in the event of low venous pressure, a high risk of venous air embolism.
After discussion between neurosurgeon, anaesthetist and cardiac surgeon it was decided that cardiopulmonary bypass would provide the safest, most controllable and optimal surgical conditions. Complete excision of the tumour was undertaken using low systemic cardiopulmonary bypass flows and hence low cerebral blood flow. Circulatory arrest was easily achievable if required to control surgical bleeding. Cerebral protection for this period of low cerebral blood flow was achieved with general anaesthesia, optimal haemodynamics and hypothermia, while the possibility of rapidly producing deeper levels of hypothermia and circulatory arrest, if venous bleeding hampered adequate surgical excision, was immediately available.
CEREBRAL PROTECTION AND CARDIOPULMONARY BYPASS
The mechanism of hypothermic cerebral protection is no longer considered to be solely due to cerebral metabolic depression 5, 6 . Mild hypothermia is postulated to be nonspecific and have multiple mechanisms of action. These include reductions in extracellular glutamate surges and intraneuronal calcium mobilization, suppressing activation of glutamate receptors, preventing dysfunction of the blood brain barrier, preventing proliferation of microglial cells and production of superoxide anions and nitric oxide, and ameliorating the depression of protein synthesis 7 . In addition, more profound hypothermia reduces metabolic rate, preserves high-energy phosphate stores and preferentially alters cerebral lactate metabolism. Thus the protective effect of hypothermia is complex and it is possible that the relative influences of individual factors vary with different temperatures 6 .
When considering cerebral protection in neurosurgical and cardiac patients, there are a number of other clinical considerations such as cerebral perfusion pressure, pharmacological agents and the biochemical and haematological milieu that must be considered. Furthermore, dose-dependent hypothermic cerebral protection is difficult to demonstrate. For example, in cardiac surgical patients, moderate hypothermic cardiopulmonary bypass (<28°C) has not been shown to provide additional benefit over mild hypothermic (>34°C) cardiopulmonary bypass 8 . It seems that under certain conditions further reductions in temperature may be of no additional benefit. This makes clinical recommendations regarding hypothermic cerebral protection difficult to develop and at present the relationship between cerebral protection, cerebral perfusion and temperature is not clearly understood. What the optimal or adequate perfusion pressure is for a certain temperature during a specific period of potential cerebral ischaemia is unknown. From historical precedent, we know that profound hypothermia is useful for periods of no flow and provides protection for up to one hour of circulatory arrest during paediatric cardiac and adult neurovascular surgery 9 .
If hypothermia shows consistent cerebral protection, is there any benefit in the addition of pharmacological agents to provide additional protection? The traditional thought is that anaesthetic agents provide cerebral protection by reducing cerebral metabolic rate to a point limited by electroencephalogram (EEG) silence, while hypothermia provides further reductions below this. At deep hypothermic-induced EEG silence there is thus no further reduction in cerebral metabolic rate (CMRO 2 ) with additional anaesthetic agents 10 . In the presence of EEG activity, further reductions do occur and it has been hypothesized that only in this situation is pharmacological EEG suppression of potential benefit 11 . This is a theory that has not been tested in clinical or histopathological studies.
Under conditions of normothermic focal ischaemia, a number of anaesthetic agents have been shown to provide a degree of cerebral protection. Thiopentone has consistently been shown to provide protection to the same degree or better than volatile anaesthetic agents 12, 13 , and despite conflicting results, there is more consistent evidence for its protective effect than for any other drug 14 . However whether this is a dose-dependent effect has recently been questioned. In a recent study in a rat model of focal ischaemia, pentobarbital was shown to provide a similar degree of protection irrespective of whether it achieved burst suppression or not 15 . That is, its protective ability seemed independent of cerebral metabolic rate.
Looking at the additional benefit of anaesthetic agents during moderate hypothermic cardiopulmonary bypass, the only study in humans suggesting additional benefit of thiopentone was in open cardiac procedures 16 with a bubble oxygenator, no arterial filter and with nasopharyngeal temperatures >34°C. This benefit was unable to be replicated using closed cardiac procedures, membrane oxygenator, arterial filter and temperature of 28°C 17 , indicating that thiopentone was only beneficial in surgery associated CASE REPORT with a high risk of micro-embolization or in the absence of hypothermia.
Thiopentone, when given to achieve burst suppression in association with cardiopulmonary bypass at 20°C, results in lower oxygen delivery but not lower CMRO 2 18 . Additionally, thiopentone prevents the normal increase in concentration of high-energy phosphate that occurs during hypothermic cardiopulmonary bypass 19 .
In summary, at present there is no convincing evidence that the addition of anaesthetic agents once moderate or deep hypothermia is achieved provides additional benefit, and there is some evidence that it may be detrimental. Whether they provide some benefit at the time of cannulation and decannulation when only mild hypothermia will be present is unknown.
Our rationale for lowering this patient's temperature to 24°C was that if bleeding became excessive and circulatory arrest was needed, further reduction in temperature to levels proven safe for circulatory arrest could be readily achieved. Additionally the reduction in temperature would provide some cerebral protection during this period of reduced cerebral blood flow. It was presumed that at 24°C, an arterial pressure of 50 mmHg, a flow rate of 30 ml/kg/min and mixed venous oxygen saturation of 85% indicated adequate total body and presumably cerebral oxygenation to meet metabolic requirements. Our aim was to maintain venous oxygen saturation greater than 75% at all times. However under hypothermic conditions, the reduction in cerebral metabolic rate is lower and does not correlate with reductions in total body metabolic rate 20 . Hence interpretation of total body oxygen consumption should be used with caution.
Although deep hypothermia with consequent circulatory arrest has traditionally been used for cerebral protection, there is considerable experimental work and clinical studies from paediatric cardiac surgical patients that preservation of low flow cardiopulmonary bypass compared with circulatory arrest is associated with a better neurological outcome. In two prospective randomized studies, low flow was associated with a better neurological outcome than cardiac standstill in children undergoing cardiac procedures 21, 22 . In a prospective study in children undergoing cardiac surgery, preservation of low flow was shown to prevent cerebral lactate release 23 , and in animals at 15°C, a flow of 10 ml/kg/min preserves high-energy phosphate and intracellular pH 24 .
Experimental studies have provided some information on the lower safe limits for flow rates. Rebeyka 25 showed that at 25°C and a mean arterial pressure less than 30 mmHg, as CPB flow rates decreased, cortical adenosine triphosphate levels fell linearly and cortical lactate levels increased, and that the threshold flow for incurring functional cerebral injury was 1 l/min/m 2 . Mohri 26 showed that at 25°C and a mean arterial pressure of 40 to 50 mmHg, a flow rate of at least 40 ml/kg/min was needed to maintain cerebral integrity. Miyamoto 27 showed that at 20°C the optimal perfusion flow rate for the brain was 30 ml/kg/min, with a possible oxygen debt and anaerobic metabolism if the perfusion flow rate was less than 15ml/kg/min. While Swain 24 showed at 15°C and mean arterial pressure of 40 to 50 mmHg that a flow rate of only 10 ml/kg/min was required to preserve high energy phosphate and intracellular pH.
Contrary to these, in a study of pigs cooled to 18°C, Scheller 28 showed that at a mean arterial pressure of less than 20 mmHg and with flow rates of 10 ml/kg/min, neuronal Golgi abnormalities were greater than in a similar group with cardiac standstill, suggesting that there is a lower limit at which low flow provides no further benefit and may even be detrimental. These authors also point out the possibility of different physiological parameters such as carbon dioxide tension, anaesthetic and anaesthetic depth, haematocrit and brain temperature influencing results.
Taken together, these studies show that as temperature is reduced, the minimum flow rate to avoid cerebral injury is also reduced. They also provide some lower limits for perfusion practice. Interpretation of the data for application to humans, particularly in the presence of vascular pathology, should be used with caution.
Deep hypothermia results in loss of pressure flow autoregulation and an attenuated reactivity to carbon dioxide tension, impairing cerebral vascular relaxation leading to a cold-induced vasoparesis 29 . Recent studies at 18°C show that cerebral metabolism was reduced to 32 to 40% of baseline, instead of the expected 12% 30 , and after CPB involving either a period of low flow or no flow, there is an initial hyperaemia followed by a period of increased cerebral vascular resistance for as much as eight hours following rewarming, despite the return of normal cerebral metabolism 20, 31 . Thus there is a significant period of increased susceptibility to ischaemia immediately after rewarming which necessitates an increased oxygen extraction. This leads some authors to recommend the measurement of jugular venous oxygen saturation as an indicator of potential neurological injury. The increased cerebral vascular resistance is N. BURGESS, P. ISERT minimized when low flow rather than circulatory arrest is used 32 , is unrelated to the rate of rewarming 33 but is attenuated by a period of cold reperfusion 34, 35 or by blockage of thromboxane A 2 receptors 36 .
Another clinical controversy is whether alpha stat or pH stat management provides better cerebral protection during hypothermic cardiopulmonary bypass. Alpha stat, which preserves autoregulation and prevents cerebral hyperaemia at moderate hypothermia, has been shown to provide a better neurological outcome in adults undergoing standard coronary procedures [37] [38] [39] .
Results from animal experiments and paediatric cardiac patients raise concerns that pH stat management under deep hypothermic circulatory arrest may provide better cerebral protection. One retrospective study 40 and one randomized prospective study 41 in paediatric cardiac patients have shown better neurological outcome with pH stat management. It is suggested that decreased cerebral blood flow with alpha stat results in inadequate, non-homogenous brain cooling before circulatory arrest. In neonates it has been shown that inadequate reduction in cerebral metabolism as indicated by an inadequate elevation in jugular mixed venous oxygen saturation prior to hypothermic circulatory arrest is a predictor of neurological deficits 42 . Two studies in newborn piglets 21, 43 confirm this non-homogenous distribution of cerebral blood flow showing an increase in per cent distribution to the basal ganglia, cerebellum, pons and medulla oblongata with pH stat compared with alpha stat management.
Compared with alpha stat management, pH stat management provides more rapid recovery of intracellular pH and cerebral adenosine triphosphate 44 as well as a 30 to 40% reduction in cerebral oxygen consumption with slower cortical deoxygenation at 17°C 45, 46 . Whether these features can be extrapolated to the adult population and if this applies to low flow cardiopulmonary bypass in addition to cardiac standstill is unclear. It is also unclear if a more prolonged period of cooling or the use of adjuvant vasodilators to facilitate a more even cooling can negate these features. In paediatric cardiac patients, low flow cardiopulmonary bypass may have patterns of cerebral ischaemia similar to those seen in deep hypothermic circulatory arrest 47 . Additionally, a small study in adults showed alpha stat management with cooling rates of 1° to 3°C/min was inadequate prior to hypothermic cardiac arrest 48 . The evidence therefore raises some concerns about the use of alpha stat but does not prove the benefit of using pH stat management in adult neurosurgical patients.
During cardiopulmonary bypass it has been shown that a period of rapid rewarming is accompanied by a greater increase in cerebral metabolic rate than with a period of slower rewarming, and this increased cerebral metabolic rate is unmatched by increased cerebral blood flow 49 , therefore placing the brain at risk from ischaemia. Rapid rewarming has the added potential risk of cerebral hyperthermia 50 . This leads some authors to advocate gradual increase in perfusate temperature to a maximum of 40°C and not to exceed a gradient of 10°C between perfusate and venous blood. Animal studies indicate that cerebral rewarming is independent of pH or alpha stat management 43 .
MONITORING
In most of the literature prior to the appreciation that even mild hypothermia can significantly alter outcome from cerebral ischaemia, temperature was an unstated or biasing factor. Only recently has it become apparent that monitoring brain temperature directly is the only reliable method of accurately determining cerebral temperature. In a study by Stone 52 on 27 patients undergoing neurosurgical procedures under deep hypothermic circulatory arrest comparing eight peripheral sites with cerebral cortex, none of the monitoring sites correlated with cerebral temperature throughout the entire period. Nasopharyngeal, oesophageal and pulmonary artery had the closest correlation, although individual patient variations make the use of one site unreliable on its own.
In an effort to ensure adequate metabolic suppression prior to periods of hypotension or potential circulatory arrest, different monitoring modalities have been suggested. Traditionally electroencephalography (EEG) has been used with the conventional assumption that an isoelectric EEG correlates with optimal protection. In clinical studies there is no consistent relationship between body temperature at various sites and onset of electrocerebral silence 53 , implying that temperature itself cannot be relied upon as a sole indicator of metabolic suppression. With deep hypothermia, if electrical activity persists, it is common to administer a pharmacological agent to provide enhanced cerebral protection by further metabolic suppression, although this practice remains unproven in humans. Limitations of using intraoperative EEG to detect or warn against cerebral ischaemia during hypothermia are shown in studies of adults at 28 to 32°C during cardiopulmonary bypass where EEG was not found to be useful in detecting ischaemia 54 . Thus the only proven CASE REPORT indication for EEG is the detection of electrical silence or gross abnormalities intraoperatively. It may be useful for detecting epileptiform activity on rewarming 55 .
Most evoked potentials decrease with hypothermia and eventually disappear at 20 to 23°C, limiting their usefulness as an intraoperative monitor. Somatosensory evoked potentials seem less sensitive to temperature changes, and have been advocated as a monitor for cerebral ischaemia during hypothermic low flow cardiopulmonary bypass at 20°C 56 . However further reduction in temperature limits these as a useful indicator of intraoperative cerebral ischaemia, although abnormalities during rewarming may be a useful indicator of ischaemia 9, 57 . Other monitoring modalities assessing cerebral oxygenation include jugular venous oxygen saturation 31 and near infrared spectroscopy 58 . At present there are no outcome studies of monitors which demonstrate a benefit, and limited comparative studies defining which is the most sensitive and clinically useful monitor for intraoperative ischaemia.
CANNULATION: CENTRAL VERSUS PERIPHERAL
Traditionally cardiopulmonary bypass for complex neurovascular lesions has been initiated with femoral cannulation 19, 59, 60 , although, if adequate flow rates can not be achieved, central cannulation may still be required. Most institutions have shown preference for femoral cannulation in the non-atherosclerotic patient, because of its lower morbidity than central cannulation. Femoral bypass may be complicated by femoral artery occlusion (2.5%), femoral pseudoaneurysm (0.8%), deep vein thrombosis (0.8%), haematoma (5.4%) 61 , groin infection (6.6%) 62 , and even compartment syndrome 63 . With the use of femoral bypass, some authors 60 advocate perioperative trans-oesophageal echocardiography to exclude aortic regurgitation, aid in the positioning of the right atrial cannulae and to monitor for left ventricular distension, which can occur even in the absence of aortic regurgitation, and prevent reversion to sinus rhythm during defibrillation 1 . Other authors use femoral bypass without trans-oesophageal echocardiography 59 . Our choice of central cannulation was based on our opinion that femoral cannulation and femorofemoral bypass would not guarantee rapid and reliable changes in systemic venous and thus cerebral venous pressure during resection. Additionally, it was our opinion that central cannulation provided more predictable total body and cerebral cooling and rewarming, and possibly better control over cerebral blood flow. To date this is an unstudied area with no comparative study available.
To our knowledge, this case is the first reported use of a hemi-sternotomy for cardiopulmonary access associated with a neurosurgical procedure. Hemisternotomy has previously been described for both mitral and aortic valve replacements 64, 65 . Compared with full sternotomy, it prevents the risk of sternal dehiscence associated with infection, has no risk of incisional or epigastric hernia, less risk of traction on the brachial plexus and a better cosmetic result. It has been suggested that a partial sternotomy may shorten hospital stay and be associated with less pain 64 , but this has not been confirmed in a subsequent study 66 . This approach offers an attractive alternative for neurosurgical procedures requiring central cannulation, by avoiding potential complications of femorofemoral bypass and decreasing risks compared with those of full sternotomy.
COAGULATION
Hypothermic cardiopulmonary bypass has a number of significant haematological considerations. The increased viscosity at low temperatures necessitates lowering of the haematocrit, however the optimum level at a given temperature has not been clearly defined. Reversible platelet dysfunction and a decrease in platelet count secondary to haemodilution and hypothermic-induced vascular sequestration occurs but resolves within one to two hours of rewarming, with complete normalization of function within two to four hours. Hypothermia leads to a slowing of the enzymatic coagulation cascade, again a condition that resolves within one to two hours of rewarming. Hypothermia to 28°C causes a prolongation of 50 to 60% in activated partial thromboplastin time and prothrombin time 67 , which corrects to normal at normothermia. Standard laboratory tests are measured at 37°C and therefore do not accurately reflect haemostasis at lower temperatures. Studies using thromboelastography at 33 to 34°C show a reversible abnormality in clot formation but not in absolute clot strength 68 , suggesting that the appropriate treatment for hypothermic-induced coagulopathy is adequate rewarming, and platelet and coagulation factors should only be administered when results of coagulation studies performed at normothermia are abnormal. The practical consideration is that full correction will take one to two hours after rewarming which would necessitate a delay in closing the craniotomy in order to prevent development of an expanding intracerebral haematoma.
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In an effort to minimize the use of systemic heparin, heparin-coated CPB circuit components have been developed. These have certain limitations, they still require administration of a reduced dose of heparin prior to cannulation and they cannot be used without full heparinization in cases where there is likely to be stagnant blood, for example cardiac standstill, or with the use of a reservoir (which in some situations acts as an air trap for patients at high risk of air entrainment) 69 . There is some additional concern regarding the co-administration of aprotinin leading to hypercoagulability, with some authors advocating full heparinization even in the presence of heparincoated circuits when aprotinin is used 59 .
The use of aprotinin during hypothermic CPB and circulatory arrest is a controversial issue. A number of retrospective reviews have been published in patients having circulatory arrest for thoracic aneurysms. Rooney 70 suggested that it was of no benefit but he did not administer it until after circulatory arrest. Two studies using both high dose 71 and low dose 72 regimens show a beneficial effect on bleeding if commenced prior to bypass with no statistically significant deleterious outcome, however blood coagulation and fibrinolytic studies showed a subclinical hypercoagulability 72 . This was countered in both studies by using adequate heparinization to keep the activated clotting time >500 seconds (as measured by Kaolin activator) or >750 seconds (celite). It should also be noted that the study by Okita 72 used retrograde cerebral perfusion, thus the application to neurosurgical procedures needs to be questioned. At present there is no proven deleterious outcome, but similarly, no definite proof of benefit.
CONCLUSION
In summary we present a case of a meningioma involving the superior sagittal sinus where cardiopulmonary bypass was used to provide optimal surgical conditions for excision. Cardiopulmonary bypass was initiated to control cerebral venous pressure and flow, rather than arterial pressure as in previously described uses of cardiopulmonary bypass for neurosurgical procedures. We have highlighted some of the relevant anaesthetic issues when managing patients with complex neurovascular lesions under hypothermic cardiopulmonary bypass, and describe an alternative for cardiovascular cannulation. Clinical recommendations are difficult to make because the only studies looking specifically at adult neurosurgical patients are reviews over a prolonged period of time with limited numbers.
